Ping LiuBrooklyn, NY

Ping Liu Phones & Addresses

Brooklyn, NY

Mentions for Ping Liu

Professional Records

Lawyers & Attorneys

Ping Liu Photo 1

Ping Liu - Lawyer

Address:
Jsm Beijing Representative Office.
(106) 599-9333 (Office)
Licenses:
New York - Currently registered 2005
Education:
Harvard

Medicine Doctors

Ping Liu

Specialties:
Internal Medicine
Work:
Newton Memorial Medical Center Hospitalist
175 High St FL 3, Newton, NJ 07860
(973) 383-2121 (phone) (973) 579-8807 (fax)
Education:
Medical School
Tongji Med Univ, Wuhan City, Hubei, China
Graduated: 1992
Conditions:
Acute Pancreatitis, Bacterial Pneumonia, Cardiac Arrhythmia, Cholelethiasis or Cholecystitis, Chronic Bronchitis, Dementia, Diverticulitis, Fractures, Dislocations, Derangement, and Sprains, Gastritis and Duodenitis, Gastrointestinal Hemorrhage, Intestinal Obstruction, Iron Deficiency Anemia, Ischemic Stroke, Osteomyelitis, Overweight and Obesity, Pneumonia, Poisoning by Drugs, Meds, or Biological Substances, Pulmonary Embolism, Transient Cerebral Ischemia, Abdominal Aortic Aneurysm, Abdominal Hernia, Abnormal Vaginal Bleeding, Acute Bronchitis, Acute Myocardial Infarction (AMI), Acute Renal Failure, Acute Sinusitis, Acute Upper Respiratory Tract Infections, Alcohol Dependence, Alzheimer's Disease, Anemia, Angina Pectoris, Anxiety Dissociative and Somatoform Disorders, Anxiety Phobic Disorders, Aortic Valvular Disease, Arterial Thromboembolic Disease, Atherosclerosis, Atrial Fibrillation and Atrial Flutter, Bell's Palsy, Benign Paroxysmal Positional Vertigo, Benign Prostatic Hypertrophy, Bipolar Disorder, Bladder Cancer, Breast Disorders, Bronchial Asthma, Calculus of the Urinary System, Candidiasis, Candidiasis of Vulva and Vagina, Cardiomyopathy, Carditis, Chronic Pancreatitis, Chronic Renal Disease, Chronic Sinusitis, Cirrhosis, Conduction Disorders, Constipation, Cystic Fibrosis (CF, Dehydration, Depressive Disorders, Dermatitis, Diabetes Mellitus (DM), Diabetic Peripheral Neuropathy, Diabetic Retinopathy, Disorders of Lipoid Metabolism, Diverticulosis, Emphysema, Endocarditis, Endometriosis, Epilepsy, Esophagitis, Femoral Hernia, Gastric Cancer, Gastroesophageal Reflux Disease (GERD), Gout, Heart Failure, Hemolytic Anemia, Hemorrhagic stroke, Hemorrhoids, Hypertension (HTN), Hyperthyroidism, Hypoglycemic Coma, Hypoparathyroidism, Hypothyroidism, Infectious Diseases of the Brain or Spinal Cord, Infectious Liver Disease, Inflammatory Bowel Disease (IBD), Influenza, Inguinal Hernia, Intervertebral Disc Degeneration, Intracranial Injury, Irritable Bowel Syndrome (IBS), Ischemic Bowel Disease, Ischemic Heart Disease, Kidney Cancer, Liver Cancer, Lung Cancer, Lyme Disease, Malignant Neoplasm of Colon, Malignant Neoplasm of Esophagus, Malignant Neoplasm of Female Breast, Meningitis, Migraine Headache, Mitral Valvular Disease, Multiple Myeloma, Multiple Sclerosis (MS), Myasthenia Gravis (MG), Nephrotic Syndrome, Non-Hodgkin's Lymphoma, Obsessive-Compulsive Disorder (OCD), Obstructive Sleep Apnea, Orbital Infection, Osteoarthritis, Osteoporosis, Otitis Media, Pancreatic Cancer, Parkinson's Disease, Paroxysmal Supreventricular Tachycardia (PSVT), Peptic Ulcer Disease, Pericardidtis, Peripheral Nerve Disorders, Post Traumatic Stress Disorder (PTSD), Rectal, Abdomen, Small Intestines, or Colon Cancer, Restless Leg Syndrome, Rheumatoid Arthritis, Sarcoidosis, Schizophrenia, Septicemia, Sickle-Cell Disease, Skin and Subcutaneous Infections, Spinal Stenosis, Substance Abuse and/or Dependency, Systemic Lupus Erythematosus, Thyroid Cancer, Tinea Unguium, Urinary Tract Infection (UT), Valvular Heart Disease, Varicose Veins, Venous Embolism and Thrombosis, Viral Meningitis, Viral Pneumonia
Languages:
English
Description:
Dr. Liu graduated from the Tongji Med Univ, Wuhan City, Hubei, China in 1992. She works in Newton, NJ and specializes in Internal Medicine. Dr. Liu is affiliated with Overlook Medical Center.
Ping Liu Photo 2

Ping Liu

Specialties:
Internal Medicine

Resumes

Resumes

Ping Liu Photo 3

Ping Liu

Work:
Ping Liu 2014 to 2000
Principal Statistician
3M Pharmaceuticals, Inc May 2005 to Feb 2012
Statistician/lead statistician on several
US and Europe Aug 2000 to Apr 2005
Lead statistician in Actinic Keratosis project
University of Minnesota Sep 1998 to Jun 2000
Consultant
Education:
The University of Texas 2007 to 2012
Ph.D in Biostatistics
University of Minnesota 1998 to 2000
M.S in Biostatistics
Fudan University 1992 to 1997
B.S in Genetics & Genetic Engineering
Fudan University

Business Records

Name / TitleCompany / ClassificationPhones & Addresses
Ping Liu
PRESIDENT
ASIAN RESTAURANT INC 83 Broad St, Middletown, CT 06457
7 Division St 2Fl, New York, NY 10002
Ping Liu
Manager
Cuspress, LLC

Publications

Us Patents

Substituted Amides

US Patent:
6972295, Dec 6, 2005
Filed:
Mar 12, 2003
Appl. No.:
10/387265
Inventors:
William K. Hagmann - Westfield NJ,
Linus S. Lin - Westfield NJ,
Shrenik K. Shah - Metuchen NJ,
Ravindra N. Guthikonda - Edison NJ,
Hongbo Qi - Edison NJ,
Linda L. Chang - Wayne NJ,
Ping Liu - Edison NJ,
Helen M. Armstrong - Westfield NJ,
James P. Jewell - Jersey City NJ,
Assignee:
Merck & Co., Inc. - Rahway NJ
International Classification:
A61K031/4412
C07D213/70
US Classification:
514345, 546290
Abstract:
Novel compounds of the structural formula (I) are antagonists and/or inverse agonists of the Cannabinoid-1 (CB1) receptor and are useful in the treatment, prevention and suppression of diseases mediated by the CB1 receptor. The compounds of the present invention are useful as centrally acting drugs in the treatment of psychosis, memory deficits, cognitive disorders, migraine, neuropathy, neuro-inflammatory disorders including multiple sclerosis and Guillain-Barre syndrome and the inflammatory sequelae of viral encephalitis, cerebral vascular accidents, and head trauma, anxiety disorders, stress, epilepsy, Parkinson's disease, movement disorders, and schizophrenia. The compounds are also useful for the treatment of substance abuse disorders, the treatment of obesity or eating disorders, as well as the treatment of asthma, constipation, chronic intestinal pseudo-obstruction, and cirrhosis of the liver.

Vla-4 Antagonists

US Patent:
7514409, Apr 7, 2009
Filed:
Mar 7, 2005
Appl. No.:
10/591820
Inventors:
William K. Hagmann - Westfield NJ,
Linus S. Lin - Westfield NJ,
Ping Liu - Westfield NJ,
Richard A. Mumford - Red Bank NJ,
Thomas S. Reger - San Diego CA,
Nicholas D. Smith - San Diego CA,
Nicholas S. Stock - San Diego CA,
Jasmine Zunic - San Diego CA,
Assignee:
Merck & Co., Inc. - Rahway NJ
International Classification:
A61K 38/05
US Classification:
514 19
Abstract:
Compounds of Formula I are antagonists of VLA-4, and as such are useful in the inhibition or prevention of cell adhesion and cell-adhesion mediated pathologies. These compounds may be formulated into pharmaceutical compositions and are suitable for use in the treatment of inflammatory bowel disease including ulcerative colitis and Crohn's disease, multiple sclerosis, asthma, and rheumatoid arthritis.

Substituted Pyridyoxy Amides

US Patent:
7550489, Jun 23, 2009
Filed:
Feb 1, 2008
Appl. No.:
12/012463
Inventors:
William K. Hagmann - Westfield NJ,
Linus S. Lin - Westfield NJ,
Shrenik K. Shah - Metuchen NJ,
Ravindra N. Guthikonda - Edison NJ,
Hongbo Qi - Edison NJ,
Linda L. Chang - Wayne NJ,
Ping Liu - Edison NJ,
Helen M. Armstrong - Westfield NJ,
James P. Jewell - Jersey City NJ,
Assignee:
Merck & Co., Inc. - Rahway NJ
International Classification:
A61K 31/435
US Classification:
514354, 514355
Abstract:
Novel compounds of the structural formula (I) are antagonists and/or inverse agonists of the Cannabinoid-1 (CB1) receptor and are useful in the treatment, prevention and suppression of diseases mediated by the CB1 receptor. The compounds of the present invention are useful as centrally acting drugs in the treatment of psychosis, memory deficits, cognitive disorders, migraine, neuropathy, neuro-inflammatory disorders including multiple sclerosis and Guillain-Barre syndrome and the inflammatory sequelae of viral encephalitis, cerebral vascular accidents, and head trauma, anxiety disorders, stress, epilepsy, Parkinson's disease, movement disorders, and schizophrenia. The compounds are also useful for the treatment of substance abuse disorders, the treatment of obesity or eating disorders, as well as the treatment of asthma, constipation, chronic intestinal pseudo-obstruction, and cirrhosis of the liver.

Substituted Amides

US Patent:
7816534, Oct 19, 2010
Filed:
Apr 16, 2009
Appl. No.:
12/386336
Inventors:
William K. Hagmann - Westfield NJ,
Linus S. Lin - Westfield NJ,
Shrenik K. Shah - Metuchen NJ,
Ravindra N. Guthikonda - Edison NJ,
Hongbo Qi - Edison NJ,
Linda L. Chang - Wayne NJ,
Ping Liu - Edison NJ,
Helen M. Armstrong - Westfield NJ,
James P. Jewell - Jersey City NJ,
Assignee:
Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:
A61K 31/44
C07D 213/04
C07D 401/02
C07D 403/02
C07D 239/02
US Classification:
546255, 546266, 5462681, 544238, 514256, 514336, 514340
Abstract:
Novel compounds of the structural formula (I) are antagonists and/or inverse agonists of the Cannabinoid-1 (CB1) receptor and are useful in the treatment, prevention and suppression of diseases mediated by the CB1 receptor. The compounds of the present invention are useful as centrally acting drugs in the treatment of psychosis, memory deficits, cognitive disorders, migraine, neuropathy, neuro-inflammatory disorders including multiple sclerosis and Guillain-Barre syndrome and the inflammatory sequelae of viral encephalitis, cerebral vascular accidents, and head trauma, anxiety disorders, stress, epilepsy, Parkinson's disease, movement disorders, and schizophrenia. The compounds are also useful for the treatment of substance abuse disorders, the treatment of obesity or eating disorders, as well as the treatment of asthma, constipation, chronic intestinal pseudo-obstruction, and cirrhosis of the liver.

Substituted Diazepine Sulfonamides As Bombesin Receptor Subtype-3 Modulators

US Patent:
8153626, Apr 10, 2012
Filed:
Dec 7, 2007
Appl. No.:
12/517836
Inventors:
Robert K. Baker - Cranford NJ,
Linda L. Chang - Wayne NJ,
Marc Chioda - Metuchen NJ,
Harry R. Chobanian - Aberdeen NJ,
Yan Guo - Westfield NJ,
Linus S. Lin - Westfield NJ,
Ping Liu - Westfield NJ,
Ravi P. Nargund - East Brunswick NJ,
Kathleen M. Rupprecht - Cranford NJ,
Shouwu Miao - Edison NJ,
Assignee:
Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:
A01N 43/62
A61K 31/55
C07D 491/00
C07D 513/00
C07D 515/00
C07D 243/10
C07D 487/12
US Classification:
514220, 540557
Abstract:
Certain novel substituted diazepine sulfonamides are ligands of the human bombesin receptor and, in particular, are selective ligands of the human bombesin receptor subtype-3 (BRS-3). They are therefore useful for the treatment, control, or prevention of diseases and disorders responsive to the modulation of BRS-3, such as obesity, and diabetes.

Imidazole Derivatives Useful As Inhibitors Of Faah

US Patent:
8455528, Jun 4, 2013
Filed:
Jun 4, 2009
Appl. No.:
12/996429
Inventors:
Linus S. Lin - Westfield NJ,
Marc D. Chioda - Metuchen NJ,
Ping Liu - Westfield NJ,
Ravi P. Nargund - East Brunswick NJ,
Assignee:
Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:
A61K 31/4174
A61K 31/4178
C07D 233/84
US Classification:
514397, 5483111
Abstract:
The present invention is directed to certain imidazole derivatives which are useful as inhibitors of Fatty Acid Amide Hydrolase (FAAH). The invention is also concerned with pharmaceutical formulations comprising these compounds as active ingredients and the use of the compounds and their formulations in the treatment of certain disorders, including osteoarthritis, rheumatoid arthritis, diabetic neuropathy, postherpetic neuralgia, skeletomuscular pain, and fibromyalgia, as well as acute pain, migraine, sleep disorder, Alzeimer Disease, and Parkinson's Disease.

Substituted Amides

US Patent:
2005023, Oct 20, 2005
Filed:
Apr 19, 2005
Appl. No.:
11/109076
Inventors:
William Hagmann - Westfield NJ,
Linus Lin - Westfield NJ,
Shrenik Shah - Metuchen NJ,
Ravindra Guthikonda - Edison NJ,
Hongbo Qi - Edison NJ,
Linda Chang - Wayne NJ,
Ping Liu - Edison NJ,
Helen Armstrong - Westfield NJ,
James Jewell - Jersey City NJ,
Thomas Lanza - Edison NJ,
International Classification:
A61K031/502
A61K031/428
A61K031/423
A61K031/4196
A61K031/405
A61K031/401
A61K031/165
US Classification:
514248000, 514367000, 514375000, 514423000, 514419000, 514617000, 514383000, 544237000, 548152000, 548217000, 548495000, 548537000
Abstract:
Novel compounds of the structural formula (I) are antagonists and/or inverse agonists of the Cannabinoid-1 (CB1) receptor and are useful in the treatment, prevention and suppression of diseases mediated by the CB1 receptor. The compounds of the present invention are useful as centrally acting drugs in the treatment of psychosis, memory deficits, cognitive disorders, migraine, neuropathy, neuro-inflammatory disorders including multiple sclerosis and Guillain-Barre syndrome and the inflammatory sequelae of viral encephalitis, cerebral vascular accidents, and head trauma, anxiety disorders, stress, epilepsy, Parkinson's disease, movement disorders, and schizophrenia. The compounds are also useful for the treatment of substance abuse disorders, the treatment of obesity or eating disorders, as well as the treatment of asthma, constipation, chronic intestinal pseudo-obstruction, and cirrhosis of the liver.

Acyclic Hydrazides As Cannabinoid Receptor Modulators

US Patent:
2008007, Mar 27, 2008
Filed:
Oct 3, 2005
Appl. No.:
11/661834
Inventors:
Linus Lin - Westfield NJ,
Ping Liu - Westfield NJ,
International Classification:
A61K 31/4412
A61K 31/165
A61P 25/00
C07C 243/12
C07D 213/63
US Classification:
514351000, 514615000, 546300000, 564149000, 564151000
Abstract:
The acyclic hydrazides of the invention are antagonists and/or inverse agonists of the Cannabinoid-1 (CB1) receptor and are useful in the treatment, prevention and suppression of diseases mediated by the CB1 receptor. The compounds of the present invention are useful as centrally acting drugs in the treatment of psychosis, memory deficits, cognitive disorders, migraine, neuropathy, neuro-inflammatory disorders including multiple sclerosis and Guillain-Barre syndrome and the inflammatory sequelae of viral encephalitis, cerebral vascular accidents, and head trauma, anxiety disorders, stress, epilepsy, Parkinson's disease, movement disorders, and schizophrenia. The compounds are also useful for the treatment of substance abuse disorders (including smoking cessation), the treatment of obesity or eating disorders, as well as the treatment of asthma, constipation, chronic intestinal pseudo-obstruction, and cirrhosis of the liver.

All data offered is derived from public sources. We do not verify or evaluate each piece of data, and makes no warranties or guarantees about any of the information offered. We do not possess or have access to secure or private financial information. People Background Check is not a credit reporting agency and does not offer consumer reports. None of the information offered by People Background Check is to be considered for purposes of determining any entity or person's eligibility for credit, insurance, employment, housing, or for any other purposes covered under the FCRA.